Back to News
Market Impact: 0.2
Kazia Announces Pricing Of ADSs And Warrants In Offering Worth $80 Mln; Stock Drops Over 15%
Source: Nasdaq
IPOs & SPACsCorporate EarningsCompany Fundamentals
Kazia Therapeutics (KZIA) priced a public offering of up to $80 million worth of American Depositary Shares (ADSs). The announcement may modestly pressure sentiment given dilution risk, but provides incremental capital for its oncology development efforts.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.10
Ticker Sentiment
KZIA-0.10
More News
- Take Five: Bangkok blues
- ‘If nothing is done, it’s almost inevitable’: Ukraine’s Yuriy Ryzhenkov on why steelmaking is on the brink of collapse as Russian bombing intensifies
- Why is LG Innotek stock plunging today?
- TotalEnergies, KKR expand U.S. solar venture with 700 MW addition
- TSMC expected to report sixth straight quarter of record profit thanks to AI boom
- Vår Energi cuts 2026 output forecast; Q3 production at 369,000 boepd